Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Language
English
Source: News from NEI - Category: Opthalmology Authors: Jason Source Type: news
More News: Blindness | Clinical Trials | Gene Therapy | Genetics | Health | National Institutes of Health (NIH) | Opthalmology | Retinitis Pigmentosa | Study